Vericel®

Vericel Corporation is a leader in advanced cell therapies for the sports medicine and severe burn care markets. The company generates revenue primarily through the commercialization of its FDA-approved products, including MACI® for cartilage repair and Epicel® for treating severe burns. Founded in 1989, Vericel has a rich history of innovation in regenerative medicine, with a strong focus on improving patient outcomes through cutting-edge cellular therapies.

Recent Posts by Vericel®

1-9 of 9